16 September 2026 editorial review · Item
Australian T1D National Screening Pilot: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: corrected/updated. Current item
lastReviewed: 2026-09-16. - Claim check: Pilot protocol compares three screening models, with genetic enrichment distinct from antibody diagnosis. Corrected claim that no general-population screen can be requested: Type1Screen now offers wider access. School pilot and system investment remain research, not universal service.
- Primary publication/regulatory sources checked or consulted: PMID 39129150.
- Programme/sponsor/conference source boundary: Type 1 Diabetes National Screening Pilot (official study site) (registry); Australian Type 1 Diabetes National Screening Pilot: advancing the evidence base towards national public health implementation (manufacturer); National T1D screening supported with nearly $10m from Breakthrough T1D (manufacturer).